And also common treatments with Lupron (leuprolide) or Zoladex (goserelin) is frequently not available and/or much too highly-priced. Lately developed ADT treatments such as abiraterone and enzalutamide are totally out of arrive at financially for some African sufferers and sometimes not accessible in any respect in lower- and reduced-Center-money